Net loss of GW Pharmaceuticals from 2017 to 2020
In 2020, GW Pharmaceuticals reported a net loss of around 58 million U.S. dollars, which is a significant improvement from nearly 300 million U.S. dollars of reported loss in 2018. This statistic illustrates the net loss of GW Pharmaceuticals worldwide from 2017 to 2020. In May 2021, the company was acquired by Ireland-based biopharma company Jazz Pharmaceuticals.